PHIO
Phio Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
PHIO fundamentals
During Q4 2025, Phio Pharmaceuticals (PHIO) reported revenue of --, a YoY change of 0.00%. Net income was -2.37M, a YoY change of -45.82%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2015 | Q3,2015 | Q4,2015 | Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Apr 1, 2015 | Jul 1, 2015 | Oct 1, 2015 | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Jun 30, 2015 | Sep 30, 2015 | Dec 31, 2015 | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | 0 -- | 10.00K -- | 9.00K -- | -- -- | 0 -- | -- -- | 0 -100.00% | 0 -- | 15.00K -- | 23.00K -- | 58.00K -- | 57.00K -- | 0 -100.00% | 21.00K -8.70% | 0 -100.00% | 0 -100.00% | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Sales and Services Revenue | -- -- | -- -- | 0 -- | 10.00K -- | 9.00K -- | -- -- | 0 -- | -- -- | 0 -100.00% | 0 -- | 15.00K -- | 23.00K -- | 58.00K -- | 57.00K -- | 0 -100.00% | 21.00K -8.70% | 0 -100.00% | 0 -100.00% | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -- -- | -- -- | 0 -- | 10.00K -- | 9.00K -- | -- -- | 0 -- | -- -- | 0 -100.00% | 0 -- | 15.00K -- | 23.00K -- | 58.00K -- | 57.00K -- | 0 -100.00% | 21.00K -8.70% | 0 -100.00% | 0 -100.00% | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 2.17M -- | 2.50M -- | 2.62M -- | 2.25M -- | 2.22M +2.73% | 2.22M -11.50% | 2.34M -10.79% | 7.08M +214.01% | 2.51M +13.04% | 2.48M +11.73% | 2.01M -14.24% | 2.26M -68.06% | 1.96M -22.16% | 1.55M -37.44% | 1.73M -13.56% | 2.17M -4.20% | 2.06M +5.21% | 2.11M +36.41% | 2.67M +53.92% | 2.36M +8.72% | 1.67M -18.94% | 2.31M +9.13% | 2.46M -7.76% | 3.64M +54.41% | 2.68M +60.81% | 3.74M +62.14% | 3.45M +40.13% | 2.64M -27.43% | 2.52M -6.07% | 3.57M -4.49% | 2.73M -20.87% | 3.60M +36.44% | 2.55M +1.03% | 2.78M -22.26% | 1.90M -30.44% | 2.21M -38.67% | 1.91M -24.85% | 1.59M -42.72% | 1.67M -11.85% | 1.87M -15.26% | 2.31M +20.64% | 2.50M +57.55% | 2.53M +51.37% | 9.22M -- |
Selling, General and Administrative Expenses | 804.00K -- | 770.00K -- | 899.00K -- | 950.00K -- | 885.00K +10.07% | 752.00K -2.34% | 1.03M +14.79% | 1.12M +18.21% | 1.10M +24.29% | 986.00K +31.12% | 802.00K -22.29% | 901.00K -19.77% | 774.00K -29.64% | 711.00K -27.89% | 790.00K -1.50% | 1.08M +19.64% | 913.00K +17.96% | 1.07M +50.63% | 1.65M +108.35% | 1.14M +5.57% | 890.00K -2.52% | 1.05M -1.96% | 2.00M +21.45% | 1.21M +6.24% | 1.13M +26.40% | 1.07M +1.52% | 1.23M -38.72% | 1.05M -12.82% | 1.22M +8.18% | 1.06M -0.28% | 1.12M -8.90% | 1.47M +39.28% | 1.16M -4.35% | 968.00K -8.94% | 766.00K -31.36% | 1.06M -27.72% | 1.05M -9.97% | 946.00K -2.27% | 689.00K -10.05% | 986.00K -7.07% | 1.24M +17.84% | 1.32M +39.96% | 1.06M +53.41% | 4.60M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 5.08M -- | -- -- | -- -- | -- -- | 4.63M -8.90% | -- -- | -- -- | -- -- | 4.45M -3.78% | -- -- | -- -- | 968.00K -- | 766.00K -82.79% | 1.06M -- | 1.05M -- | 946.00K -2.27% | 689.00K -10.05% | 986.00K -7.07% | 1.24M +17.84% | 1.32M +39.96% | 1.06M +53.41% | 4.60M -- |
Research and Development Expenses | 1.36M -- | 1.73M -- | 1.72M -- | 1.30M -- | 1.34M -1.62% | 1.46M -15.57% | 1.31M -24.14% | 1.35M +3.22% | 1.33M -0.75% | 1.49M +1.78% | 1.20M -7.88% | 1.36M +1.04% | 1.18M -10.99% | 838.00K -43.76% | 944.00K -21.59% | 1.09M -19.99% | 1.15M -3.13% | 1.04M +24.34% | 1.02M +8.37% | 1.22M +11.85% | 779.00K -32.02% | 1.26M +20.54% | 463.00K -54.74% | 2.43M +99.43% | 1.56M +100.13% | 2.67M +112.82% | 2.23M +380.56% | 1.59M -34.71% | 1.30M -16.36% | 2.51M -6.17% | 1.61M -27.46% | 2.13M +34.55% | 1.38M +6.06% | 1.81M -27.91% | 1.01M -37.61% | 1.15M -46.20% | 866.00K -37.38% | 644.00K -64.38% | 985.00K -2.18% | 886.00K -22.82% | 1.07M +24.02% | 1.18M +83.39% | 1.48M +49.95% | 4.62M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 126.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 4.61M -- | 85.00K -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -2.17M -- | -2.50M -- | -2.62M -- | -2.25M -- | -2.21M -2.31% | -2.22M +11.50% | -2.34M +10.79% | -7.08M -215.41% | -2.51M -13.50% | -2.48M -11.73% | -1.99M +14.88% | -2.24M +68.38% | -1.90M +24.46% | -1.49M +39.74% | -1.73M +12.91% | -2.15M +4.15% | -2.06M -8.43% | -2.11M -41.62% | -2.67M -53.92% | -2.36M -9.79% | -1.67M +18.94% | -2.31M -9.13% | -2.46M +7.76% | -3.64M -54.41% | -2.68M -60.81% | -3.74M -62.14% | -3.45M -40.13% | -2.64M +27.43% | -2.52M +6.07% | -3.57M +4.49% | -2.73M +20.87% | -3.60M -36.44% | -2.55M -1.03% | -2.78M +22.26% | -1.90M +30.44% | -2.21M +38.67% | -1.91M +24.85% | -1.59M +42.72% | -1.67M +11.85% | -1.87M +15.26% | -2.31M -20.64% | -2.50M -57.55% | -2.53M -51.37% | -9.22M -- |
Non-Operating Income (Loss) | -1.00K -- | 8.00K -- | 6.00K -- | 14.00K -- | 3.00K +400.00% | 8.00K -- | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -100.00% | -11.00K -- | 0 -- | -2.00K -- | -1.00K -- | 7.00K +163.64% | 27.00K -- | 24.00K +1300.00% | 19.00K +2000.00% | 9.00K +28.57% | 5.00K -81.48% | -3.00K -112.50% | -3.00K -115.79% | 0 -100.00% | 231.00K +4520.00% | -3.00K -- | -3.00K -- | -1.00K -- | -2.00K -100.87% | -10.00K -233.33% | -5.00K -66.67% | -1.00K -- | 0 +100.00% | -2.00K +80.00% | -4.00K +20.00% | 4.00K +500.00% | 55.00K -- | 68.00K +3500.00% | 66.00K +1750.00% | 48.00K +1100.00% | 103.00K +87.27% | 143.00K +110.29% | 113.00K +71.21% | 163.00K +239.58% | 522.00K -- |
Other Non-Operating Income (Loss) | -2.00K -- | -- -- | 0 -- | 7.00K -- | -1.00K +50.00% | 4.00K -- | 0 -- | 0 -100.00% | 0 +100.00% | 0 -100.00% | -11.00K -- | 0 -- | -2.00K -- | -1.00K -- | 7.00K +163.64% | 27.00K -- | 24.00K +1300.00% | 19.00K +2000.00% | 9.00K +28.57% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 231.00K -- | -3.00K -- | -3.00K -- | -1.00K -- | -2.00K -100.87% | -10.00K -233.33% | -5.00K -66.67% | -1.00K -- | 0 +100.00% | -2.00K +80.00% | -4.00K +20.00% | 12.00K +1300.00% | 2.00K -- | 68.00K +3500.00% | 0 +100.00% | 6.00K -50.00% | -22.00K -1200.00% | 143.00K +110.29% | 0 -- | 0 -100.00% | 121.00K -- |
Net Interest Expense | -1.00K -- | -8.00K -- | -6.00K -- | -7.00K -- | -4.00K -300.00% | -4.00K +50.00% | 0 +100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -5.00K -- | 3.00K -- | 3.00K -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 8.00K -- | -53.00K -- | -- -- | -66.00K -- | -42.00K -625.00% | -125.00K -135.85% | -- -- | -113.00K -71.21% | -163.00K -288.10% | -- -- |
Pretax Income From Continuing Operations | -2.17M -- | -2.50M -- | -2.62M -- | -2.23M -- | -2.21M -2.12% | -2.21M +11.54% | -2.34M +10.59% | -7.08M -217.39% | -2.51M -13.65% | -2.48M -12.14% | -2.00M +14.41% | -2.24M +68.38% | -1.90M +24.38% | -1.49M +39.70% | -1.73M +13.74% | -2.12M +5.36% | -2.04M -7.05% | -2.09M -40.25% | -2.66M -54.02% | -2.35M -10.95% | -1.67M +17.84% | -2.31M -10.27% | -2.46M +7.44% | -3.41M -44.92% | -2.69M -60.71% | -3.74M -62.06% | -3.45M -40.17% | -2.64M +22.45% | -2.53M +5.81% | -3.58M +4.44% | -2.73M +20.86% | -3.60M -36.34% | -2.55M -0.71% | -2.78M +22.26% | -1.90M +30.61% | -2.15M +40.20% | -1.85M +27.58% | -1.52M +45.18% | -1.63M +14.20% | -1.77M +17.87% | -2.17M -17.33% | -2.39M -56.96% | -2.37M -45.82% | -8.70M -- |
Income Tax Expense | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -1.62M -- | 0 -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -2.17M -- | -2.50M -- | -2.62M -- | -2.23M -- | -2.21M -2.12% | -2.21M +11.54% | -2.34M +10.59% | -5.46M -144.73% | -2.51M -13.65% | -2.48M -12.14% | -2.00M +14.41% | -2.24M +58.99% | -1.90M +24.38% | -1.49M +39.70% | -1.73M +13.74% | -2.12M +5.36% | -2.04M -7.05% | -2.09M -40.25% | -2.66M -54.02% | -2.35M -10.95% | -1.67M +17.84% | -2.31M -10.27% | -2.46M +7.44% | -3.41M -44.92% | -2.69M -60.71% | -3.74M -62.06% | -3.45M -40.17% | -2.64M +22.45% | -2.53M +5.81% | -3.58M +4.44% | -2.73M +20.86% | -3.60M -36.34% | -2.55M -0.71% | -2.78M +22.26% | -1.90M +30.61% | -2.15M +40.20% | -1.85M +27.58% | -1.52M +45.18% | -1.63M +14.20% | -1.77M +17.87% | -2.17M -17.33% | -2.39M -56.96% | -2.37M -45.82% | -8.70M -- |
Net Income Attributable to Owners of the Company | -2.17M -- | -2.50M -- | -2.62M -- | -2.23M -- | -2.21M -2.12% | -2.21M +11.54% | -2.34M +10.59% | -5.46M -144.73% | -2.51M -13.65% | -2.48M -12.14% | -2.00M +14.41% | -2.24M +58.99% | -1.90M +24.38% | -1.49M +39.70% | -1.73M +13.74% | -2.12M +5.36% | -2.04M -7.05% | -2.09M -40.25% | -2.66M -54.02% | -2.35M -10.95% | -1.67M +17.84% | -2.31M -10.27% | -2.46M +7.44% | -3.41M -44.92% | -2.69M -60.71% | -3.74M -62.06% | -3.45M -40.17% | -2.64M +22.45% | -2.53M +5.81% | -3.58M +4.44% | -2.73M +20.86% | -3.60M -36.34% | -2.55M -0.71% | -2.78M +22.26% | -1.90M +30.61% | -2.15M +40.20% | -1.85M +27.58% | -1.52M +45.18% | -1.63M +14.20% | -1.77M +17.87% | -2.17M -17.33% | -2.39M -56.96% | -2.37M -45.82% | -8.70M -- |
Preferred Stock Dividends | 24.00K -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 2.08M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -2.19M -- | -2.50M -- | -2.62M -- | -2.23M -- | -2.21M -1.00% | -2.21M +11.54% | -4.41M -68.73% | -5.46M -144.73% | -2.51M -13.65% | -2.48M -12.14% | -2.00M +54.64% | -2.24M +58.99% | -1.90M +24.38% | -1.49M +39.70% | -1.73M +13.74% | -2.12M +5.36% | -2.04M -7.05% | -2.09M -40.25% | -2.66M -54.02% | -2.35M -10.95% | -1.67M +17.84% | -2.31M -10.27% | -2.46M +7.44% | -3.41M -44.92% | -2.69M -60.71% | -3.74M -62.06% | -3.45M -40.17% | -2.64M +22.45% | -2.53M +5.81% | -3.58M +4.44% | -2.73M +20.86% | -3.60M -36.34% | -2.55M -0.71% | -2.78M +22.26% | -1.90M +30.61% | -2.15M +40.20% | -1.85M +27.58% | -1.52M +45.18% | -1.63M +14.20% | -1.77M +17.87% | -2.17M -17.33% | -2.39M -56.96% | -2.37M -45.82% | -8.70M -- |
Other Comprehensive Income | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -2.17M -- | -2.50M -- | -2.62M -- | -2.23M -- | -2.21M -2.12% | -2.21M +11.54% | -2.34M +10.59% | -5.46M -144.73% | -2.51M -13.65% | -2.48M -12.14% | -2.00M +14.41% | -2.24M +58.99% | -1.90M +24.38% | -1.49M +39.70% | -1.73M +13.74% | -2.12M +5.36% | -2.04M -7.05% | -2.09M -40.25% | -2.66M -54.02% | -2.35M -10.95% | -1.67M +17.84% | -2.31M -10.27% | -2.46M +7.44% | -3.41M -44.92% | -2.69M -60.71% | -3.74M -62.06% | -3.45M -40.17% | -2.64M +22.45% | -2.53M +5.81% | -3.58M +4.44% | -2.73M +20.86% | -3.60M -36.34% | -2.55M -0.71% | -- -- | -10.83M -296.41% | -2.15M +40.20% | -1.85M +27.58% | -- -- | -- -- | -1.77M +17.87% | -2.17M -17.33% | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -2.17M -- | -2.50M -- | -2.62M -- | -2.23M -- | -2.21M -2.12% | -2.21M +11.54% | -2.34M +10.59% | -5.46M -144.73% | -2.51M -13.65% | -2.48M -12.14% | -2.00M +14.41% | -2.24M +58.99% | -1.90M +24.38% | -1.49M +39.70% | -1.73M +13.74% | -2.12M +5.36% | -2.04M -7.05% | -2.09M -40.25% | -2.66M -54.02% | -2.35M -10.95% | -1.67M +17.84% | -2.31M -10.27% | 6.33M +338.05% | -3.41M -44.92% | -2.69M -60.71% | -3.74M -62.06% | 9.84M +55.34% | -2.64M +22.45% | -2.53M +5.81% | -3.58M +4.44% | 8.75M -11.05% | -3.60M -36.34% | -2.55M -0.71% | -- -- | -- -- | -- -- | -1.85M +27.58% | -1.52M -- | 5.52M -- | -- -- | -2.17M -17.33% | -2.39M -56.96% | 6.33M +14.54% | -- -- |
Basic EPS | -0.5 -- | -0.38 -- | -- -- | -0.34 -- | -0.34 +32.00% | -0.34 +10.53% | -0.34 -- | -2.65 -679.41% | -1.12 -229.41% | -1.05 -208.82% | -0.82 -141.18% | -0.9 +66.04% | -0.46 +58.93% | -0.34 +67.62% | -0.09 +89.02% | -5.71 -534.44% | -4.62 -904.35% | -4.53 -1232.35% | -0.07 +22.22% | -1.33 +76.71% | -0.34 +92.64% | -0.4 +91.17% | -0.43 -514.29% | -0.32 +75.94% | -0.2 +41.18% | -0.28 +30.00% | -0.25 +41.86% | -2.34 -631.25% | -2.22 -1010.00% | -3.14 -1021.43% | -0.2 +20.00% | -3.15 -34.62% | -13.27 -497.75% | -10.25 -226.43% | -0.51 -155.00% | -0.47 +85.08% | -3.62 +72.72% | -1.54 +84.98% | -0.94 -84.31% | -0.41 +12.77% | -0.45 +87.57% | -0.44 +71.43% | -0.2 +78.72% | -1.5 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -10.25 -- | -- -- | -0.47 -- | -3.62 -- | -1.54 +84.98% | -- -- | -0.41 +12.77% | -0.45 +87.57% | -0.44 +71.43% | -- -- | -- -- |
Diluted EPS | -0.5 -- | -0.38 -- | -- -- | -0.34 -- | -0.34 +32.00% | -0.34 +10.53% | -- -- | -2.65 -679.41% | -1.12 -229.41% | -1.05 -208.82% | -- -- | -0.9 +66.04% | -0.46 +58.93% | -0.34 +67.62% | -- -- | -5.71 -534.44% | -4.62 -904.35% | -4.53 -1232.35% | -- -- | -1.33 +76.71% | -0.34 +92.64% | -0.4 +91.17% | -- -- | -0.32 +75.94% | -0.2 +41.18% | -0.28 +30.00% | -- -- | -2.34 -631.25% | -2.22 -1010.00% | -3.14 -1021.43% | -- -- | -3.15 -34.62% | -13.27 -497.75% | -10.25 -226.43% | -- -- | -0.47 +85.08% | -3.62 +72.72% | -1.54 +84.98% | -- -- | -0.41 +12.77% | -0.45 +87.57% | -0.44 +71.43% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -10.25 -- | -- -- | -0.47 -- | -3.62 -- | -1.54 +84.98% | -- -- | -0.41 +12.77% | -0.45 +87.57% | -0.44 +71.43% | -- -- | -- -- |
You can ask Aime
What is Phio Pharmaceuticals's gross profit margin?What were the key takeaways from Phio Pharmaceuticals’s earnings call?What guidance did Phio Pharmaceuticals's management provide for the next earnings period?What is Phio Pharmaceuticals's latest dividend and current dividend yield?Did Phio Pharmaceuticals beat or miss consensus estimates last quarter?What is the market's earnings forecast for Phio Pharmaceuticals next quarter?What factors drove the changes in Phio Pharmaceuticals's revenue and profit?What were the key takeaways from Phio Pharmaceuticals's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
